Xconomy: Novartis News, Articles and Opinions

“novartis” Archives

Entry	Author	Date	Location
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More	Ben Fidler	04/19/19	National
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help	Frank Vinluan	04/18/19	Boston
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants	Ben Fidler	04/18/19	Boston
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon	Ben Fidler	04/15/19	New York
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy	Ben Fidler	04/15/19	National
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More	Frank Vinluan	04/05/19	National
Report: Biogen, Novartis Should Drop Prices of Billon-Dollar SMA Drugs	Alex Lash	04/04/19	Boston
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results	Ben Fidler	04/03/19	National
Novartis Adds Inflammation Drugs to Pipeline with Deal for IFM Tre	Frank Vinluan	04/01/19	Boston
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services	Jeff Buchanan	03/27/19	Seattle
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More	Frank Vinluan	03/15/19	National
Clinical Analytics Platform TriNetX Raises $40M to Speed Drug Trials	Brian Dowling	03/13/19	Boston
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski	Ben Fidler	03/11/19	National
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy	Frank Vinluan	03/04/19	Raleigh Durham
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar	Ben Fidler	03/04/19	Boston
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark	Ben Fidler	03/01/19	National
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans	Frank Vinluan	02/28/19	San Francisco
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away	Alex Lash	02/26/19	National
Novartis to Pay $150M to Ionis, Akcea for Drug to Slow Heart Disease	Sarah de Crescenzo	02/25/19	San Diego
TCR²’s IPO Raises $75M to Bring Cancer Cell Therapy to Solid Tumors	Frank Vinluan	02/14/19	Boston
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More	Frank Vinluan	02/01/19	National
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy	Ben Fidler	01/31/19	New York
Aduro Biotech Slashes Staff 37%, Turns Focus to Lead Cancer Drugs	Frank Vinluan	01/30/19	San Francisco
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More	Alex Lash	01/11/19	National
Pfizer, GSK to Merge Consumer Health Units, Focus on Prescription Drugs	Ben Fidler	12/19/18	National
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2)	Ben Fidler	12/18/18	National
Merck Beefs Up Animal Health Unit with $2.4B Antelliq Acquisition	Frank Vinluan	12/14/18	New York
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More	Frank Vinluan	12/14/18	National
Pear Therapeutics App Gets FDA Nod for Treating Opioid Abuse	Jeff Engel	12/11/18	Boston
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO	Ben Fidler	12/07/18	National
Page 1 of 23	next page »